Discipline of Exercise and Sport Science, University of Sydney, Australia.
J Hepatol. 2012 Jul;57(1):157-66. doi: 10.1016/j.jhep.2012.02.023. Epub 2012 Mar 10.
BACKGROUND & AIMS: Exercise is an integral component of lifestyle intervention aimed at weight loss, but an independent benefit of exercise in NAFLD has also been suggested.
We aimed to evaluate the efficacy of aerobic exercise and/or progressive resistance training for the modulation of liver fat and alanine aminotransferase (ALT) levels in adults. Relevant databases were searched up to August 2011 for controlled trials, which compared regular exercise vs. a non-exercise control on change in liver fat and/or ALT.
Of the 16,822 studies from the initial search, 12 were included. There was a significant pooled effect size (ES) for the comparison between exercise therapy vs. control (ES=-0.37, 95% CI: -0.06 to -0.69; p=0.02), but only when interventions which compared combined exercise and diet vs. diet-alone and achieved substantial weight loss, were omitted. The benefit of exercise on liver fat occurred with minimal or no weight loss. There was no effect of exercise alone vs. control on ALT (ES=-0.15, 95% CI: 0.14 to -0.45; p=0.32).
Individual reports of exercise interventions often have low sample sizes and insufficient power to detect clinically meaningful hepatic benefits. By pooling current research, we show clear evidence for a benefit of exercise therapy on liver fat but not ALT levels. This benefit is apparent with minimal or no weight loss and at exercise levels below current exercise recommendations for obesity management. Given the paucity of current treatment options, exercise provides a valid, low-cost therapy for disorders characterised by fatty liver.
运动是旨在减肥的生活方式干预的一个组成部分,但也有人提出运动对非酒精性脂肪性肝病(NAFLD)有独立的益处。
我们旨在评估有氧运动和/或渐进性抗阻训练对成年人肝脏脂肪和丙氨酸氨基转移酶(ALT)水平调节的疗效。截至 2011 年 8 月,我们对相关数据库进行了检索,以寻找比较常规运动与非运动对照组肝脏脂肪和/或 ALT 变化的对照试验。
从最初的搜索中,有 16822 项研究,其中 12 项被纳入。与对照组相比,运动疗法的效果有显著的总体效应大小(ES)(ES=-0.37,95%CI:-0.06 至-0.69;p=0.02),但仅当比较联合运动和饮食与单纯饮食且实现显著体重减轻的干预措施时,才会排除。运动对肝脏脂肪的益处发生在体重减轻很少或没有的情况下。单独运动与对照组对 ALT 没有影响(ES=-0.15,95%CI:0.14 至-0.45;p=0.32)。
个别运动干预报告的样本量通常较小,不足以检测到有临床意义的肝脏益处。通过汇集目前的研究,我们清楚地证明了运动疗法对肝脏脂肪有明显的益处,但对 ALT 水平没有益处。这种益处明显存在于体重减轻很少或没有的情况下,而且运动水平低于目前肥胖管理的运动建议。鉴于目前治疗选择有限,运动为以脂肪肝为特征的疾病提供了一种有效的、低成本的治疗方法。